Latest Overdiagnosis Stories
Foundation for Improving Prostate Imaging Technology Testifies at House Committee for Hearing WASHINGTON, March 4 /PRNewswire-USNewswire/ -- AdMeTech President and CEO Dr. Faina Shtern told the U.S.
Health Care Reform Highlights Need for Better Screening and Prevention Foundation for Improving Prostate Imaging Technology Praises House Committee for Hearing WASHINGTON, March 1 /PRNewswire-USNewswire/ -- AdMeTech Foundation announced today that its President and CEO Dr.
Officials at the American Psychiatric Association are proposing major changes to its diagnostic bible, the manual that doctors, insurers and scientists use in deciding what is officially a mental disorder and what symptoms to treat.
More conservative treatment, or watchful waiting of localized prostate cancer may be why outcomes have improved, U.S researchers said. Grace L.
A comparison of outcomes of different eras of conservative treatment for localized prostate cancer indicates that overall and prostate cancer-specific survival rates are higher for men diagnosed from 1992 through 2002 compared to men diagnosed in the 1970s and 1980s, according to a study in the September 16 issue of JAMA.
A public survey conducted in Europe found that the vast majority of people overestimate the life-saving benefits of breast and prostate cancer screening, according to a new study published online August 12 in the Journal of the National Cancer Institute.
The July issue of European Urology, the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) with the results from the Prostate
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA
- Growing in low tufty patches.